David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 9,000 shares at $17.86 ($161K) on 2009-09-15, disclosed to the SEC on 2009-09-16.
Open-market sale of $161k THRX by Head of Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |